These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19). Laterre PF; François B; Collienne C; Hantson P; Jeannet R; Remy KE; Hotchkiss RS JAMA Netw Open; 2020 Jul; 3(7):e2016485. PubMed ID: 32697322 [TBL] [Abstract][Full Text] [Related]
30. The trinity of COVID-19: immunity, inflammation and intervention. Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093 [TBL] [Abstract][Full Text] [Related]
31. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19. Dong H Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359 [No Abstract] [Full Text] [Related]
32. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711 [TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review. Razmi M; Hashemi F; Gheytanchi E; Dehghan Manshadi M; Ghods R; Madjd Z Int Immunopharmacol; 2020 Nov; 88():106942. PubMed ID: 32896750 [TBL] [Abstract][Full Text] [Related]
34. Obesity, COVID-19 and immunotherapy: the complex relationship! Finelli C Immunotherapy; 2020 Oct; 12(15):1105-1109. PubMed ID: 32677493 [No Abstract] [Full Text] [Related]
35. COVID-19: an Immunopathological View. Kadkhoda K mSphere; 2020 Apr; 5(2):. PubMed ID: 32321823 [TBL] [Abstract][Full Text] [Related]
36. Covid-19: Perspectives on Innate Immune Evasion. Taefehshokr N; Taefehshokr S; Hemmat N; Heit B Front Immunol; 2020; 11():580641. PubMed ID: 33101306 [TBL] [Abstract][Full Text] [Related]
37. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment. Abid MB; Mughal M; Abid MA JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719 [No Abstract] [Full Text] [Related]
38. Complement as a target in COVID-19? Risitano AM; Mastellos DC; Huber-Lang M; Yancopoulou D; Garlanda C; Ciceri F; Lambris JD Nat Rev Immunol; 2020 Jun; 20(6):343-344. PubMed ID: 32327719 [TBL] [Abstract][Full Text] [Related]